Malanos Dimitrios

Malanos Dimitrios Dermatologist

Attending Physician, Dermatology Department HYGEIA Hospital

Education & Academic Qualifications

  • Medical Degree, Faculty of Medicine, University of Athens, Greece
  • Diplomate of the Hellenic Board of Dermatology-Venereology
  • Certified in Dermatology and Venereology
  • PhD in Dermatology at the University of Athens, Greece
  • Clinical Research Fellow, Department of Dermatology, Beth Israel Hospital, Harvard Medical School, Boston, MA
  • International Dermoscopy/Dermato-Oncology Diploma, Medical University of Graz, Austria


Fellowship in Societies, Membership in Journal Editorial Committees

  • Hellenic Society of Dermatology and Venereology 

  • Hellenic Society of Dermatologic Surgery

  • Hellenic Dermoscopy Society

  • European Association of Dermato Oncology

  • International Dermoscopy Society


Work Experience

  • Attending Physician, Department of Dermatology, Hygeia Hospital, Athens, Greece (since 2010) 

  • Clinical/Research Fellow in Dermatology at the University Clinic of Andreas Sygros Hospital, Athens, Greece (2009-2012)

Education Experience:

  • Teaching Dermatology in Institutions of Vocational training (Ι.Ε.Κ)


Clinical & Research Interest

  • Skin cancer-Melanoma-Dermoscopy 

  • Psoriasis

  • Dermatosurgery

  • Lasers in Dermatology


Honors & Awards

  • Second Clinical Award for the presentation titled: “Correlation of immunologic and virus indications in the development of classic Kaposi’s Sarcoma. VIII Congress of Dermatology – Venereology in Thessaloniki, Greece. (2003)

Recent Publications

  • Malanos D and Stern R. Psoralen plus ultraviolet A does not increase the risk of cataracts: a 25-year prospective study. J Am Acad Dermatol.2007 Aug;57(2):231-7. 

  • Stratigos AJ, Malanos D, Touloumi G,Antoniou A,Potouridou E, PolydorouD, Katsambas AD, Whitby D, Mueller N, Stratigos JD, Hatzakis A. Clinical progression in classic Kaposi’s Sarcoma is associated with a reduction of peripheral B-lymphocytes and a partial increase in serum immune activation markers.( Accepted for publication in Arch Dermatol.)